 |
인쇄하기
취소
|
ViroMed to conduct phase II trial of VM202
ViroMed president Kim Sung-young said that she had a meeting with some of the US investigators and clinicians in New Orleans on November 8 in order to further evaluate the clinical benefit of VM202 through its planned Phase II trial.
In the US in phase I, a dose-escalation study, was carried out in Minneapolis Heart Institute to assess the safety and efficacy in the patients with critical li...
In the US in phase I, a dose-escalation study, was carried out in Minneapolis Heart Institute to assess the safety and efficacy in the patients with critical li...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.